Overview

The Effects of Nitazoxanide in Hepatic Encephalopathy

Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
Evaluating the efficacy and safety of nitazoxanide in comparison to standard treatment in patients with grade II-III hepatic encephalopathy (HE). Also, Evaluating the effect of administering nitazoxanide on the improvement of patient's quality of life.
Phase:
Phase 2
Details
Lead Sponsor:
Ain Shams University
Collaborator:
Al-Azhar University
Treatments:
Lactulose
Metronidazole
Nitazoxanide